CoChat

Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants

Open access
Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., Sachs, G. · 2006 · Psychiatric Services
Cited by 121

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: This study assessed patterns of psychopharmacological treatment for bipolar disorder. METHOD: Intake treatment data were examined for the first 500 patients in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (1998 to 1999). Diagnoses were assessed by using the Structured Clinical Interview for DSM-IV mood modules. Data on treatments were obtained by interviewing patients during the initial psychiatric examination. RESULTS: Of the 500 participants, 73.6 percent had bipolar I disorder, 23.0 percent had bipolar II disorder, and 3.4 percent had bipolar disorder not otherwise specified. Upon examination, 63.4 percent were euthymic, 24.6 percent were depressed, and 12.0 percent were experiencing manic, hypomanic, or mixed states. Standard mood stabilizers (lithium, valproate, or carbamazepine) were the most commonly prescribed class of drugs that participants were taking at intake (71.9 percent). The next most common class of agents was antidepressants (40.6 percent), followed by novel anticonvulsants (31.8 percent), second-generation neuroleptics (27.2 percent), and benzodiazepines (25.0 percent). Eleven percent of patients were treated with standard mood stabilizer monotherapy. These prescribing patterns were further analyzed by subtype of illness and compared with patterns in other clinical and community settings. CONCLUSION: In a large, well-characterized cross-sectional analysis of prescription patterns in the U.S. psychiatric academic setting, patients with bipolar disorder were primarily treated with standard mood stabilizers, followed by moderate use of antidepressants, novel anticonvulsants, and second-generation neuroleptics. Results can be useful in understanding the current clinical standard of care, as well as in guiding research studies toward areas in which there is a relative absence of evidence to inform clinical practice. Studies of longitudinal prescribing patterns in bipolar disorder are also needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ps.57.5.660

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 24

  1. 10.1097/00004714-199604001-00005 · DOI
  2. 10.1176/appi.ajp.159.6.1005 · DOI · Paper page
  3. Ghaemi SN, 2001, 3, 154
  4. Zarate, 1995, Journal of Clinical Psychiatry, 56, 260
  5. Ghaemi SN, 2002, Canadian Journal of Psychiatry, 47, 125, 10.1177/070674370204700202 · DOI · Paper page
  6. 10.3109/10673229409017110 · DOI
  7. 10.1034/j.1399-5618.2002.01223.x · DOI
  8. 10.1034/j.1399-5618.2001.30401.x · DOI
  9. 10.1034/j.1399-5618.2000.020205.x · DOI
  10. 10.1034/j.1399-5618.2001.030106.x · DOI
  11. 10.1034/j.1399-5618.2002.01216.x · DOI
  12. 10.1016/S0006-3223(03)00165-3 · DOI · Paper page
  13. 10.1016/S0165-0327(01)00432-3 · DOI · Paper page
  14. 10.1016/S0165-0327(00)00279-2 · DOI
  15. 10.1176/appi.ajp.161.9.1537 · DOI · Paper page
  16. 10.4088/JCP.v62n07a12 · DOI
  17. 10.1111/j.1600-0447.2004.00410.x · DOI
  18. 10.1111/j.1600-0047.2004.00295.x · DOI
  19. 10.1034/j.1600-0447.2003.00126.x · DOI
  20. 10.1192/bjp.184.4.337 · DOI · Paper page
  21. 10.1176/appi.ajp.162.7.1281 · DOI · Paper page
  22. 10.1176/appi.ajp.160.7.1263 · DOI · Paper page
  23. Marcus R, 2004, New York
  24. Ghaemi SN, 2004, Journal of Clinical Psychiatry, 65, 16

Cited by

Metadata

Authors
Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., & Sachs, G.
Venue
Psychiatric Services
Published
2006-05-01
Volume
57
Issue
5
Pages
660-665
ISSN
  • 0022-1597 (ISSN-L)
  • 1075-2730
OpenAlex
W2128861864
Cited by
121
References
8
FWCI
6.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.